All In Biotech

Drug Trial Radar · NCT02912949

A Study of Zenocutuzumab (MCLA-128) in Patients With Solid Tumors Harboring an NRG1 Fusion (eNRGy)

A Phase I/II Study of MCLA-128, a Full Length IgG1 Bispecific Antibody Targeting HER2 and HER3, in Patients With Solid Tumors (eNRGy)

Last checked: Nov 20, 2026Latest source record: Apr 29, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

250

Planned (sponsor's estimate)

Start

Jan 2015

Primary completion

Dec 31, 2026

Study completion Dec 31, 2026

Sponsor

Lead sponsor
Partner Therapeutics, Inc.Industry
Sponsor type
Industry
First posted
Sep 23, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase I/II, open-label, multi-center, multi-national, dose escalation, single agent study to assess the safety, tolerability, PK, PD, immunogenicity and anti-tumor activity of zenocutuzumab (MCLA-128) in patients with solid tumors harboring an NRG1 fusion (eNRGy)

Conditions

  • Solid Tumours Harboring NRG1 Fusion
  • NSCLC Harboring NRG1 Fusion
  • Pancreatic Cancer Harboring NRG1 Fusion
  • NRG1 Fusion

Interventions

  • zenocutuzumab (MCLA-128)Drug

    full length IgG1 bispecific antibody targeting HER2 and HER3

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective overall response rate (ORR) as per local investigator's assessmentTime frame: 36 months
  2. Duration of response per RECIST v1.1 as per local Investigator's assessment.Time frame: 36 Months

Locations

64 sites in 18 countries. Site status is shown where the registry gives one.

  • Mayo Clinic

    Phoenix, Arizona

  • The Oncology Institute of Hope and Innovation

    Cerritos, California

  • University of California Irvine

    Irvine, California

  • Stanford University

    Palo Alto, California

  • Sharp Memorial Hospital

    San Diego, California

  • Georgetown University

    Washington D.C., District of Columbia

  • Memorial Cancer Institute

    Hollywood, Florida

  • Cancer Specialists of North Florida

    Jacksonville, Florida

  • Mayo Clinic

    Jacksonville, Florida

  • Emory Winship Cancer Institute

    Atlanta, Georgia

  • Northwest Oncology & Hematology

    Rolling Meadows, Illinois

  • Dana Farber Cancer Center

    Boston, Massachusetts

  • Karmanos Cancer Center

    Detroit, Michigan

  • Mayo Clinic

    Rochester, Minnesota

  • Billings Clinic Cancer Center

    Billings, Montana

  • St. James Healthcare

    Butte, Montana

  • Memorial Sloan Kettering Cancer Center

    New York, New York

  • University of Pennsylvania

    Philadelphia, Pennsylvania

  • Averra Medical Group

    Sioux Falls, South Dakota

  • The University of Texas MD Anderson Cancer Center

    Houston, Texas

  • Huntsman Cancer Institute

    Salt Lake City, Utah

  • Utah Cancer Specialists

    Salt Lake City, Utah

  • Hematology-Oncology Specialist of Fredericksburg

    Fredericksburg, Virginia

  • Virginia Mason Hospital & Seattle Medical Center

    Seattle, Washington

  • Hematology Oncology Associates

    Spokane, Washington

  • Northwest Medical Specialties

    Tacoma, Washington

  • Salzburger Universitatsklinikum

    Salzburg, Austria

  • UZ Leuven

    Leuven, Belgium

  • Princess MargaretCancer Centre

    Toronto, Ontario, Canada

  • Rigshospitalet

    Copenhagen, Denmark

  • Centre Leon Berard

    Lyon, France

  • Hospital Louis Pradel, FR

    Lyon, France

  • Institut Gustave Roussy

    Paris, France

  • Hopital Cochin

    Paris, France

  • Hopital Curie

    Paris, France

  • Asklepios Klinik Altona

    Hamburg, Germany

  • Asklepios Kliniken Hamburg GmbH

    Hamburg, Germany

  • Deutsches Krebsforschungszentrum

    Heidelberg, Germany

  • Shaare Zedek Medical Center

    Jerusalem, Israel

  • Sheba Medical Center

    Tel Aviv, Israel

Showing 40 of 64 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.